Market Overview:
The global methocarbamol tablets market is expected to grow at a CAGR of 3.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of musculoskeletal disorders, rising geriatric population, and growing demand for pain relief drugs. By type, the global methocarbamol tablets market is segmented into 500mg/bottle and 750mg/bottle segments. The 500mg/bottle segment is expected to account for a larger share of the global methocarbamol tablets market in 2018 owing to its lower price point as compared to the 750mg/bottle segment. By application, the global methocarbamol tablets market is divided into hospital, clinics, and recovery center segments.
Product Definition:
Methocarbamol Tablets are used to relieve pain and muscle spasms. Methocarbamol Tablets are usually taken three or four times a day.
500mg/bottle:
500mg/bottle, it's usage and growth factor in Methocarbamol Tablets market? 500 mg of Methylcobalamin is the standard dosage for age-related macular degeneration. It helps to reduce the effects of dry eyes, skin lesions & cracks, and joint pain. The product also improves vision after eye surgery or injury.
750mg/bottle:
750mg/bottle is the standard dosage for metocarbamol tablets. It is also used as a generic reference in the pharmaceutical industry for tablet and capsule formulations of all pain-relieving drugs, including nonsteroidal anti-inflammatory drugs (NSAIDs), analgesic drugs, and other drug categories that are used to treat pain.
Application Insights:
The clinics segment dominated the market in 2017 and is expected to witness significant growth over the forecast period. The rising prevalence of cardiovascular diseases, respiratory disorders, cancer and other infectious diseases coupled with increasing healthcare expenditure is anticipated to drive the demand for methocarbamol tablets in clinics. Furthermore, government initiatives such as National Health Insurance Program (NHI) are expected to increase spending on healthcare which will further propel product demand in clinics by 2030.
The hospital segment accounted for a major share of the overall revenue due to growing awareness about early diagnosis and treatment of various chronic conditions among patients along with an increase in number of hospitals & recovery centers across various regions.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to increasing product consumption for pain management and prevention of muscle spasms. In addition, rising incidence of Methaemoglobinaemia in North America is anticipated to fuel demand for metocarbamol tablets over the forecast period.
Asia Pacific market was valued at USD X million in 2017 and is expected to witness lucrative growth over the projected period owing to high unmet medical needs coupled with rapidly improving healthcare infrastructure especially in developing countries such as India and China. Moreover, growing awareness regarding treatment options using non- opioid drugs will support regional growth during the estimated time span.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for methocarbamol tablets in the coming years.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as arthritis, back pain, and muscle spasms is rising rapidly across the globe, which is likely to boost the demand for methocarbamol tablets in the near future.
- Growing awareness about benefits of methocarbamol tablets: There has been a growing awareness about the benefits of methocarbamol tablets in recent years, which is likely to fuel its demand in the coming years.
- Technological advancements: The development of new and innovative technologies has led to an increase in adoption rates of methocarbamol tablets globally, thereby propelling its growth prospects over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Methocarbamol Tablets Market Research Report
By Type
500mg/bottle, 750mg/bottle
By Application
Hospital, Clinics, Recovery Center
By Companies
Endo Pharmaceuticals, Camber Pharmaceuticals, Par Pharmaceuticals, Virtus Pharmaceuticals, Hikma, Bayshore Healthcare, Granules India, Solco Healthcare, Tianjin Zhongxin Pharma, Gansu Xifeng Pharmaceutical, Jiangsu Wuzhong Pharma, Guangdong Zhongsheng Pharma, Jilin Yisheng Pharm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
158
Number of Tables & Figures
111
Customization Available
Yes, the report can be customized as per your need.
Global Methocarbamol Tablets Market Report Segments:
The global Methocarbamol Tablets market is segmented on the basis of:
Types
500mg/bottle, 750mg/bottle
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Recovery Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Endo Pharmaceuticals
- Camber Pharmaceuticals
- Par Pharmaceuticals
- Virtus Pharmaceuticals
- Hikma
- Bayshore Healthcare
- Granules India
- Solco Healthcare
- Tianjin Zhongxin Pharma
- Gansu Xifeng Pharmaceutical
- Jiangsu Wuzhong Pharma
- Guangdong Zhongsheng Pharma
- Jilin Yisheng Pharm
Highlights of The Methocarbamol Tablets Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 500mg/bottle
- 750mg/bottle
- By Application:
- Hospital
- Clinics
- Recovery Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Methocarbamol Tablets Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Methocarbamol tablets are a medication used to treat pain and inflammation. Methocarbamol is also known as Robaxin.
Some of the major players in the methocarbamol tablets market are Endo Pharmaceuticals, Camber Pharmaceuticals, Par Pharmaceuticals, Virtus Pharmaceuticals, Hikma, Bayshore Healthcare, Granules India, Solco Healthcare, Tianjin Zhongxin Pharma, Gansu Xifeng Pharmaceutical, Jiangsu Wuzhong Pharma, Guangdong Zhongsheng Pharma, Jilin Yisheng Pharm.
The methocarbamol tablets market is expected to grow at a compound annual growth rate of 3.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Methocarbamol Tablets Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Methocarbamol Tablets Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Methocarbamol Tablets Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Methocarbamol Tablets Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Methocarbamol Tablets Market Size & Forecast, 2020-2028
4.5.1 Methocarbamol Tablets Market Size and Y-o-Y Growth
4.5.2 Methocarbamol Tablets Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 500mg/bottle
5.2.2 750mg/bottle
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Recovery Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Methocarbamol Tablets Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Methocarbamol Tablets Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 500mg/bottle
9.6.2 750mg/bottle
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Recovery Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 500mg/bottle
10.6.2 750mg/bottle
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Recovery Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 500mg/bottle
11.6.2 750mg/bottle
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Recovery Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 500mg/bottle
12.6.2 750mg/bottle
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Recovery Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 500mg/bottle
13.6.2 750mg/bottle
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Recovery Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Methocarbamol Tablets Market: Competitive Dashboard
14.2 Global Methocarbamol Tablets Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Endo Pharmaceuticals
14.3.2 Camber Pharmaceuticals
14.3.3 Par Pharmaceuticals
14.3.4 Virtus Pharmaceuticals
14.3.5 Hikma
14.3.6 Bayshore Healthcare
14.3.7 Granules India
14.3.8 Solco Healthcare
14.3.9 Tianjin Zhongxin Pharma
14.3.10 Gansu Xifeng Pharmaceutical
14.3.11 Jiangsu Wuzhong Pharma
14.3.12 Guangdong Zhongsheng Pharma
14.3.13 Jilin Yisheng Pharm
